An Integrated Evaluation of Phase 1 Data Including Exposure-Response Analysis Shows Vilaprisan Does Not Delay Cardiac Repolarization

Fertility and Sterility - Netherlands
doi 10.1016/j.fertnstert.2018.07.412
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

The Impact of Non-Cardiac Drugs on the Cardiac Repolarization Phase

International Heart Journal
MedicineCardiovascular MedicineCardiology
2018English

Delay Causes and Emerging Digital Tools: A Novel Model of Delay Analysis, Including Integrated Project Delivery and PMBOK

Buildings
BuildingCivilConstructionArchitectureStructural Engineering
2019English

Single Therapeutic and Supratherapeutic Doses of Sacubitril/Valsartan (LCZ696) Do Not Affect Cardiac Repolarization

European Journal of Clinical Pharmacology
MedicinePharmacology
2016English

End-To-End Delay Analysis in an Integrated Modular Avionics Architecture

2013English

Scanning DMA Data Analysis II. Integrated DMA-CPC Instrument Response and Data Inversion

Aerosol Science and Technology
Materials SciencePollutionEnvironmental Chemistry
2018English

Modelling and Imaging Cardiac Repolarization Abnormalities

Journal of Internal Medicine
Internal Medicine
2006English

Delay Differential Analysis of Electroencephalographic Data

Neural Computation
ArtsCognitive NeuroscienceHumanities
2015English

Cholesterol Synthesis Inhibition Elicits an Integrated Molecular Response in Human Livers Including Decreased ACAT2

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2008English

Myostatin Does Not Regulate Cardiac Hypertrophy or Fibrosis

Neuromuscular Disorders
Child HealthNeurologyPediatricsPerinatologyGenetics
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy